Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

dbSNP Short Genetic Variations

Welcome to the Reference SNP (rs) Report

All alleles are reported in the Forward orientation. Click on the Variant Details tab for details on Genomic Placement, Gene, and Amino Acid changes. HGVS names are in the HGVS tab.

Reference SNP (rs) Report

This page reports data for a single dbSNP Reference SNP variation (RefSNP or rs) from the new redesigned dbSNP build.
Top of the page reports a concise summary for the rs, with more specific details included in the corresponding tabs below.
All alleles are reported in the Forward orientation. Use the Genomic View to inspect the nucleotides flanking the variant, and its neighbors.
For more information see Help documentation.

rs1051730

Current Build 156

Released September 21, 2022

Organism
Homo sapiens
Position
chr15:78601997 (GRCh38.p14) Help

The anchor position for this RefSNP. Includes all nucleotides potentially affected by this change, thus it can differ from HGVS, which is right-shifted. See here for details.

Alleles
G>A
Variation Type
SNV Single Nucleotide Variation
Frequency
A=0.243678 (64499/264690, TOPMED)
A=0.327632 (85459/260838, ALFA)
A=0.269257 (67652/251254, GnomAD_exome) (+ 24 more)
A=0.259725 (36322/139848, GnomAD)
A=0.272971 (33101/121262, ExAC)
A=0.15592 (12270/78694, PAGE_STUDY)
A=0.02074 (586/28258, 14KJPN)
A=0.02100 (352/16760, 8.3KJPN)
A=0.27192 (3529/12978, GO-ESP)
A=0.1722 (1103/6404, 1000G_30x)
A=0.1681 (842/5008, 1000G)
A=0.3232 (1448/4480, Estonian)
A=0.3236 (1247/3854, ALSPAC)
A=0.3282 (1217/3708, TWINSUK)
A=0.0229 (67/2922, KOREAN)
A=0.2207 (460/2084, HGDP_Stanford)
A=0.1617 (306/1892, HapMap)
A=0.337 (336/998, GoNL)
A=0.033 (26/792, PRJEB37584)
A=0.322 (193/600, NorthernSweden)
A=0.393 (210/534, MGP)
A=0.303 (92/304, FINRISK)
A=0.375 (81/216, Qatari)
G=0.400 (68/170, SGDP_PRJ)
A=0.31 (26/84, Ancient Sardinia)
A=0.45 (18/40, GENOME_DK)
G=0.41 (9/22, Siberian)
Clinical Significance
Reported in ClinVar
Gene : Consequence
CHRNA3 : Synonymous Variant
Publications
290 citations
Genomic View
See rs on genome

ALFA Allele Frequency
The ALFA project provide aggregate allele frequency from dbGaP. More information is available on the project page including descriptions, data access, and terms of use.

Release Version: 20231103111315
Population Group Sample Size Ref Allele Alt Allele Ref HMOZ Alt HMOZ HTRZ HWEP
Total Global 277294 G=0.675849 A=0.324151 0.462368 0.11067 0.426962 32
European Sub 232708 G=0.653845 A=0.346155 0.429319 0.121629 0.449052 5
African Sub 15606 G=0.88178 A=0.11822 0.778034 0.014482 0.207484 0
African Others Sub 540 G=0.930 A=0.070 0.862963 0.003704 0.133333 0
African American Sub 15066 G=0.88006 A=0.11994 0.77499 0.014868 0.210142 0
Asian Sub 834 G=0.970 A=0.030 0.940048 0.0 0.059952 0
East Asian Sub 660 G=0.971 A=0.029 0.942424 0.0 0.057576 0
Other Asian Sub 174 G=0.966 A=0.034 0.931034 0.0 0.068966 0
Latin American 1 Sub 1190 G=0.7782 A=0.2218 0.610084 0.053782 0.336134 0
Latin American 2 Sub 6900 G=0.8158 A=0.1842 0.670725 0.03913 0.290145 3
South Asian Sub 5048 G=0.7552 A=0.2448 0.575277 0.064976 0.359746 1
Other Sub 15008 G=0.68743 A=0.31257 0.474547 0.09968 0.425773 0


Help

Frequency tab displays a table of the reference and alternate allele frequencies reported by various studies and populations. Table lines, where Population="Global" refer to the entire study population, whereas lines, where Group="Sub", refer to a study-specific population subgroupings (i.e. AFR, CAU, etc.), if available. Frequency for the alternate allele (Alt Allele) is a ratio of samples observed-to-total, where the numerator (observed samples) is the number of chromosomes in the study with the minor allele present (found in "Sample size", where Group="Sub"), and the denominator (total samples) is the total number of all chromosomes in the study for the variant (found in "Sample size", where Group="Study-wide" and Population="Global").

Download
Study Population Group Sample Size Ref Allele Alt Allele
TopMed Global Study-wide 264690 G=0.756322 A=0.243678
Allele Frequency Aggregator Total Global 260838 G=0.672368 A=0.327632
Allele Frequency Aggregator European Sub 222542 G=0.653531 A=0.346469
Allele Frequency Aggregator Other Sub 13556 G=0.68612 A=0.31388
Allele Frequency Aggregator African Sub 10768 G=0.87890 A=0.12110
Allele Frequency Aggregator Latin American 2 Sub 6900 G=0.8158 A=0.1842
Allele Frequency Aggregator South Asian Sub 5048 G=0.7552 A=0.2448
Allele Frequency Aggregator Latin American 1 Sub 1190 G=0.7782 A=0.2218
Allele Frequency Aggregator Asian Sub 834 G=0.970 A=0.030
gnomAD - Exomes Global Study-wide 251254 G=0.730743 A=0.269257
gnomAD - Exomes European Sub 135252 G=0.655591 A=0.344409
gnomAD - Exomes Asian Sub 48986 G=0.84065 A=0.15935
gnomAD - Exomes American Sub 34584 G=0.83356 A=0.16644
gnomAD - Exomes African Sub 16250 G=0.88763 A=0.11237
gnomAD - Exomes Ashkenazi Jewish Sub 10052 G=0.61709 A=0.38291
gnomAD - Exomes Other Sub 6130 G=0.7010 A=0.2990
gnomAD - Genomes Global Study-wide 139848 G=0.740275 A=0.259725
gnomAD - Genomes European Sub 75734 G=0.65438 A=0.34562
gnomAD - Genomes African Sub 41906 G=0.88097 A=0.11903
gnomAD - Genomes American Sub 13614 G=0.76385 A=0.23615
gnomAD - Genomes Ashkenazi Jewish Sub 3322 G=0.6186 A=0.3814
gnomAD - Genomes East Asian Sub 3128 G=0.9690 A=0.0310
gnomAD - Genomes Other Sub 2144 G=0.7295 A=0.2705
ExAC Global Study-wide 121262 G=0.727029 A=0.272971
ExAC Europe Sub 73258 G=0.64800 A=0.35200
ExAC Asian Sub 25132 G=0.83575 A=0.16425
ExAC American Sub 11562 G=0.85331 A=0.14669
ExAC African Sub 10402 G=0.88454 A=0.11546
ExAC Other Sub 908 G=0.682 A=0.318
The PAGE Study Global Study-wide 78694 G=0.84408 A=0.15592
The PAGE Study AfricanAmerican Sub 32514 G=0.87716 A=0.12284
The PAGE Study Mexican Sub 10808 G=0.80968 A=0.19032
The PAGE Study Asian Sub 8318 G=0.9740 A=0.0260
The PAGE Study PuertoRican Sub 7918 G=0.7527 A=0.2473
The PAGE Study NativeHawaiian Sub 4534 G=0.8701 A=0.1299
The PAGE Study Cuban Sub 4228 G=0.6923 A=0.3077
The PAGE Study Dominican Sub 3828 G=0.7753 A=0.2247
The PAGE Study CentralAmerican Sub 2448 G=0.8325 A=0.1675
The PAGE Study SouthAmerican Sub 1982 G=0.7977 A=0.2023
The PAGE Study NativeAmerican Sub 1260 G=0.7548 A=0.2452
The PAGE Study SouthAsian Sub 856 G=0.796 A=0.204
14KJPN JAPANESE Study-wide 28258 G=0.97926 A=0.02074
8.3KJPN JAPANESE Study-wide 16760 G=0.97900 A=0.02100
GO Exome Sequencing Project Global Study-wide 12978 G=0.72808 A=0.27192
GO Exome Sequencing Project European American Sub 8586 G=0.6506 A=0.3494
GO Exome Sequencing Project African American Sub 4392 G=0.8796 A=0.1204
1000Genomes_30x Global Study-wide 6404 G=0.8278 A=0.1722
1000Genomes_30x African Sub 1786 G=0.9082 A=0.0918
1000Genomes_30x Europe Sub 1266 G=0.6209 A=0.3791
1000Genomes_30x South Asian Sub 1202 G=0.8195 A=0.1805
1000Genomes_30x East Asian Sub 1170 G=0.9726 A=0.0274
1000Genomes_30x American Sub 980 G=0.786 A=0.214
1000Genomes Global Study-wide 5008 G=0.8319 A=0.1681
1000Genomes African Sub 1322 G=0.9130 A=0.0870
1000Genomes East Asian Sub 1008 G=0.9732 A=0.0268
1000Genomes Europe Sub 1006 G=0.6312 A=0.3688
1000Genomes South Asian Sub 978 G=0.817 A=0.183
1000Genomes American Sub 694 G=0.784 A=0.216
Genetic variation in the Estonian population Estonian Study-wide 4480 G=0.6768 A=0.3232
The Avon Longitudinal Study of Parents and Children PARENT AND CHILD COHORT Study-wide 3854 G=0.6764 A=0.3236
UK 10K study - Twins TWIN COHORT Study-wide 3708 G=0.6718 A=0.3282
KOREAN population from KRGDB KOREAN Study-wide 2922 G=0.9771 A=0.0229
HGDP-CEPH-db Supplement 1 Global Study-wide 2084 G=0.7793 A=0.2207
HGDP-CEPH-db Supplement 1 Est_Asia Sub 470 G=0.943 A=0.057
HGDP-CEPH-db Supplement 1 Central_South_Asia Sub 414 G=0.691 A=0.309
HGDP-CEPH-db Supplement 1 Middle_Est Sub 350 G=0.600 A=0.400
HGDP-CEPH-db Supplement 1 Europe Sub 320 G=0.628 A=0.372
HGDP-CEPH-db Supplement 1 Africa Sub 242 G=0.880 A=0.120
HGDP-CEPH-db Supplement 1 America Sub 216 G=0.935 A=0.065
HGDP-CEPH-db Supplement 1 Oceania Sub 72 G=0.96 A=0.04
HapMap Global Study-wide 1892 G=0.8383 A=0.1617
HapMap American Sub 770 G=0.787 A=0.213
HapMap African Sub 692 G=0.910 A=0.090
HapMap Asian Sub 254 G=0.980 A=0.020
HapMap Europe Sub 176 G=0.574 A=0.426
Genome of the Netherlands Release 5 Genome of the Netherlands Study-wide 998 G=0.663 A=0.337
CNV burdens in cranial meningiomas Global Study-wide 792 G=0.967 A=0.033
CNV burdens in cranial meningiomas CRM Sub 792 G=0.967 A=0.033
Northern Sweden ACPOP Study-wide 600 G=0.678 A=0.322
Medical Genome Project healthy controls from Spanish population Spanish controls Study-wide 534 G=0.607 A=0.393
FINRISK Finnish from FINRISK project Study-wide 304 G=0.697 A=0.303
Qatari Global Study-wide 216 G=0.625 A=0.375
SGDP_PRJ Global Study-wide 170 G=0.400 A=0.600
Ancient Sardinia genome-wide 1240k capture data generation and analysis Global Study-wide 84 G=0.69 A=0.31
The Danish reference pan genome Danish Study-wide 40 G=0.55 A=0.45
Siberian Global Study-wide 22 G=0.41 A=0.59
Help

Variant Details tab shows known variant placements on genomic sequences: chromosomes (NC_), RefSeqGene, pseudogenes or genomic regions (NG_), and in a separate table: on transcripts (NM_) and protein sequences (NP_). The corresponding transcript and protein locations are listed in adjacent lines, along with molecular consequences from Sequence Ontology. When no protein placement is available, only the transcript is listed. Column "Codon[Amino acid]" shows the actual base change in the format of "Reference > Alternate" allele, including the nucleotide codon change in transcripts, and the amino acid change in proteins, respectively, allowing for known ribosomal slippage sites. To view nucleotides adjacent to the variant use the Genomic View at the bottom of the page - zoom into the sequence until the nucleotides around the variant become visible.

Genomic Placements
Sequence name Change
GRCh38.p14 chr 15 NC_000015.10:g.78601997G>A
GRCh37.p13 chr 15 NC_000015.9:g.78894339G>A
CHRNA3 RefSeqGene NG_016143.1:g.24299C>T
Gene: CHRNA3, cholinergic receptor nicotinic alpha 3 subunit (minus strand)
Molecule type Change Amino acid[Codon] SO Term
CHRNA3 transcript variant 1 NM_000743.5:c.645C>T Y [TAC] > Y [TAT] Coding Sequence Variant
neuronal acetylcholine receptor subunit alpha-3 isoform 1 precursor NP_000734.2:p.Tyr215= Y (Tyr) > Y (Tyr) Synonymous Variant
CHRNA3 transcript variant 2 NM_001166694.2:c.645C>T Y [TAC] > Y [TAT] Coding Sequence Variant
neuronal acetylcholine receptor subunit alpha-3 isoform 2 precursor NP_001160166.1:p.Tyr215= Y (Tyr) > Y (Tyr) Synonymous Variant
CHRNA3 transcript variant 3 NR_046313.2:n.847C>T N/A Non Coding Transcript Variant
CHRNA3 transcript variant X1 XM_006720382.4:c.444C>T Y [TAC] > Y [TAT] Coding Sequence Variant
neuronal acetylcholine receptor subunit alpha-3 isoform X1 XP_006720445.1:p.Tyr148= Y (Tyr) > Y (Tyr) Synonymous Variant
Help

Clinical Significance tab shows a list of clinical significance entries from ClinVar associated with the variation, per allele. Click on the RCV accession (i.e. RCV000001615.2) or Allele ID (i.e. 12274) to access full ClinVar report.

Allele: A (allele ID: 32542 )
ClinVar Accession Disease Names Clinical Significance
RCV000019055.3 Lung cancer susceptibility 2 Risk-Factor
RCV000033204.3 Smoking as a quantitative trait locus 3 Risk-Factor
Help

Aliases tab displays HGVS names representing the variant placements and allele changes on genomic, transcript and protein sequences, per allele. HGVS name is an expression for reporting sequence accession and version, sequence type, position, and allele change. The column "Note" can have two values: "diff" means that there is a difference between the reference allele (variation interval) at the placement reported in HGVS name and the reference alleles reported in other HGVS names, and "rev" means that the sequence of this variation interval at the placement reported in HGVS name is in reverse orientation to the sequence(s) of this variation in other HGVS names not labeled as "rev".

Placement G= A
GRCh38.p14 chr 15 NC_000015.10:g.78601997= NC_000015.10:g.78601997G>A
GRCh37.p13 chr 15 NC_000015.9:g.78894339= NC_000015.9:g.78894339G>A
CHRNA3 RefSeqGene NG_016143.1:g.24299= NG_016143.1:g.24299C>T
CHRNA3 transcript variant 1 NM_000743.5:c.645= NM_000743.5:c.645C>T
CHRNA3 transcript variant 1 NM_000743.4:c.645= NM_000743.4:c.645C>T
CHRNA3 transcript variant 3 NR_046313.2:n.847= NR_046313.2:n.847C>T
CHRNA3 transcript variant 3 NR_046313.1:n.1146= NR_046313.1:n.1146C>T
CHRNA3 transcript variant 2 NM_001166694.2:c.645= NM_001166694.2:c.645C>T
CHRNA3 transcript variant 2 NM_001166694.1:c.645= NM_001166694.1:c.645C>T
CHRNA3 transcript variant X1 XM_006720382.4:c.444= XM_006720382.4:c.444C>T
CHRNA3 transcript variant X1 XM_006720382.3:c.444= XM_006720382.3:c.444C>T
CHRNA3 transcript variant X1 XM_006720382.2:c.444= XM_006720382.2:c.444C>T
CHRNA3 transcript variant X2 XM_006720382.1:c.444= XM_006720382.1:c.444C>T
neuronal acetylcholine receptor subunit alpha-3 isoform 1 precursor NP_000734.2:p.Tyr215= NP_000734.2:p.Tyr215=
neuronal acetylcholine receptor subunit alpha-3 isoform 2 precursor NP_001160166.1:p.Tyr215= NP_001160166.1:p.Tyr215=
neuronal acetylcholine receptor subunit alpha-3 isoform X1 XP_006720445.1:p.Tyr148= XP_006720445.1:p.Tyr148=
Help

Submissions tab displays variations originally submitted to dbSNP, now supporting this RefSNP cluster (rs). We display Submitter handle, Submission identifier, Date and Build number, when the submission appeared for the first time. Direct submissions to dbSNP have Submission ID in the form of an ss-prefixed number (ss#). Other supporting variations are listed in the table without ss#.

163 SubSNP, 27 Frequency, 2 ClinVar submissions
No Submitter Submission ID Date (Build)
1 LEE ss1527503 Oct 05, 2000 (86)
2 WI_SSAHASNP ss6752714 Feb 20, 2003 (111)
3 HG_BONN_CNS_SNPS ss12586759 Aug 26, 2003 (117)
4 CSHL-HAPMAP ss16686526 Feb 27, 2004 (120)
5 PERLEGEN ss24450352 Sep 20, 2004 (123)
6 ILLUMINA ss66633671 Nov 30, 2006 (127)
7 ILLUMINA ss66894650 Nov 30, 2006 (127)
8 ILLUMINA ss67002526 Nov 30, 2006 (127)
9 CSHL-HAPMAP ss68382321 Jan 12, 2007 (127)
10 ILLUMINA ss70375475 May 17, 2007 (127)
11 ILLUMINA ss70490682 May 25, 2008 (130)
12 ILLUMINA ss71015211 May 17, 2007 (127)
13 ILLUMINA ss75505216 Dec 06, 2007 (129)
14 UUGC ss76901672 Dec 06, 2007 (129)
15 KRIBB_YJKIM ss83674185 Dec 15, 2007 (130)
16 CORNELL ss86272886 Mar 23, 2008 (129)
17 CNG ss98336491 Feb 05, 2009 (130)
18 SHGC ss99307503 Feb 05, 2009 (130)
19 1000GENOMES ss108966814 Jan 23, 2009 (130)
20 ILLUMINA ss121363562 Dec 01, 2009 (131)
21 ILLUMINA ss152786497 Dec 01, 2009 (131)
22 ILLUMINA ss159135491 Dec 01, 2009 (131)
23 SEATTLESEQ ss159731143 Dec 01, 2009 (131)
24 ILLUMINA ss159908614 Dec 01, 2009 (131)
25 PERLEGEN ss161151767 Dec 01, 2009 (131)
26 ILLUMINA ss169545555 Jul 04, 2010 (132)
27 ILLUMINA ss170343271 Jul 04, 2010 (132)
28 BCM-HGSC-SUB ss207219787 Jul 04, 2010 (132)
29 1000GENOMES ss226987927 Jul 14, 2010 (132)
30 1000GENOMES ss236845753 Jul 15, 2010 (132)
31 1000GENOMES ss243220619 Jul 15, 2010 (132)
32 BL ss255132764 May 09, 2011 (134)
33 GMI ss286987132 Apr 25, 2013 (138)
34 NHLBI-ESP ss342409746 May 09, 2011 (134)
35 ILLUMINA ss410887974 Sep 17, 2011 (135)
36 PAGE_STUDY ss469414507 May 04, 2012 (137)
37 PAGE_STUDY ss469415358 May 04, 2012 (137)
38 PAGE_STUDY ss469996490 May 04, 2012 (137)
39 ILLUMINA ss479312924 May 04, 2012 (137)
40 ILLUMINA ss479316024 May 04, 2012 (137)
41 ILLUMINA ss479700326 Sep 08, 2015 (146)
42 ILLUMINA ss484456772 May 04, 2012 (137)
43 1000GENOMES ss491088657 May 04, 2012 (137)
44 GSK-GENETICS ss491249729 May 04, 2012 (137)
45 EXOME_CHIP ss491497937 May 04, 2012 (137)
46 CLINSEQ_SNP ss491705171 May 04, 2012 (137)
47 ILLUMINA ss536622098 Sep 08, 2015 (146)
48 TISHKOFF ss564593482 Apr 25, 2013 (138)
49 SSMP ss660330994 Apr 25, 2013 (138)
50 ILLUMINA ss778360901 Aug 21, 2014 (142)
51 ILLUMINA ss782674941 Aug 21, 2014 (142)
52 ILLUMINA ss783643607 Aug 21, 2014 (142)
53 ILLUMINA ss825345086 Jul 19, 2016 (147)
54 ILLUMINA ss831925656 Apr 01, 2015 (144)
55 ILLUMINA ss832648157 Aug 21, 2014 (142)
56 ILLUMINA ss833238846 Aug 21, 2014 (142)
57 ILLUMINA ss833815674 Aug 21, 2014 (142)
58 JMKIDD_LAB ss974492212 Aug 21, 2014 (142)
59 EVA-GONL ss991981992 Aug 21, 2014 (142)
60 JMKIDD_LAB ss1067554683 Aug 21, 2014 (142)
61 JMKIDD_LAB ss1080267011 Aug 21, 2014 (142)
62 1000GENOMES ss1354231316 Aug 21, 2014 (142)
63 DDI ss1427685769 Apr 01, 2015 (144)
64 OMIM-CURATED-RECORDS ss1505810978 Dec 08, 2014 (142)
65 EVA_GENOME_DK ss1577713203 Apr 01, 2015 (144)
66 EVA_FINRISK ss1584095529 Apr 01, 2015 (144)
67 EVA_UK10K_ALSPAC ss1633409666 Apr 01, 2015 (144)
68 EVA_UK10K_TWINSUK ss1676403699 Apr 01, 2015 (144)
69 EVA_EXAC ss1691948724 Apr 01, 2015 (144)
70 EVA_DECODE ss1696008199 Apr 01, 2015 (144)
71 EVA_MGP ss1711405799 Apr 01, 2015 (144)
72 EVA_SVP ss1713504257 Apr 01, 2015 (144)
73 ILLUMINA ss1752172490 Sep 08, 2015 (146)
74 WEILL_CORNELL_DGM ss1935385133 Feb 12, 2016 (147)
75 ILLUMINA ss1959628676 Feb 12, 2016 (147)
76 GENOMED ss1968152663 Jul 19, 2016 (147)
77 JJLAB ss2028474142 Sep 14, 2016 (149)
78 ILLUMINA ss2094798443 Dec 20, 2016 (150)
79 ILLUMINA ss2095060252 Dec 20, 2016 (150)
80 USC_VALOUEV ss2156882693 Dec 20, 2016 (150)
81 HUMAN_LONGEVITY ss2208362371 Dec 20, 2016 (150)
82 ILLUMINA ss2633253978 Nov 08, 2017 (151)
83 ILLUMINA ss2635059730 Nov 08, 2017 (151)
84 GRF ss2701363292 Nov 08, 2017 (151)
85 ILLUMINA ss2710821053 Nov 08, 2017 (151)
86 GNOMAD ss2741435479 Nov 08, 2017 (151)
87 GNOMAD ss2749362088 Nov 08, 2017 (151)
88 GNOMAD ss2937110693 Nov 08, 2017 (151)
89 AFFY ss2985047758 Nov 08, 2017 (151)
90 AFFY ss2985683920 Nov 08, 2017 (151)
91 SWEGEN ss3013594075 Nov 08, 2017 (151)
92 ILLUMINA ss3021651901 Nov 08, 2017 (151)
93 BIOINF_KMB_FNS_UNIBA ss3028061344 Nov 08, 2017 (151)
94 CSHL ss3351199668 Nov 08, 2017 (151)
95 ILLUMINA ss3625678966 Oct 12, 2018 (152)
96 ILLUMINA ss3627406767 Oct 12, 2018 (152)
97 ILLUMINA ss3631245082 Oct 12, 2018 (152)
98 ILLUMINA ss3633103685 Oct 12, 2018 (152)
99 ILLUMINA ss3633808613 Oct 12, 2018 (152)
100 ILLUMINA ss3634616130 Oct 12, 2018 (152)
101 ILLUMINA ss3635497383 Oct 12, 2018 (152)
102 ILLUMINA ss3636306541 Oct 12, 2018 (152)
103 ILLUMINA ss3637248695 Oct 12, 2018 (152)
104 ILLUMINA ss3638097037 Oct 12, 2018 (152)
105 ILLUMINA ss3639061033 Oct 12, 2018 (152)
106 ILLUMINA ss3639536015 Oct 12, 2018 (152)
107 ILLUMINA ss3640323451 Oct 12, 2018 (152)
108 ILLUMINA ss3643080479 Oct 12, 2018 (152)
109 ILLUMINA ss3644652555 Oct 12, 2018 (152)
110 OMUKHERJEE_ADBS ss3646478153 Oct 12, 2018 (152)
111 ILLUMINA ss3652053671 Oct 12, 2018 (152)
112 ILLUMINA ss3653820045 Oct 12, 2018 (152)
113 EGCUT_WGS ss3680735443 Jul 13, 2019 (153)
114 EVA_DECODE ss3698269901 Jul 13, 2019 (153)
115 ILLUMINA ss3725516545 Jul 13, 2019 (153)
116 ACPOP ss3741087602 Jul 13, 2019 (153)
117 ILLUMINA ss3744916652 Jul 13, 2019 (153)
118 EVA ss3753326002 Jul 13, 2019 (153)
119 PAGE_CC ss3771843516 Jul 13, 2019 (153)
120 ILLUMINA ss3772415199 Jul 13, 2019 (153)
121 KHV_HUMAN_GENOMES ss3818629958 Jul 13, 2019 (153)
122 EVA ss3824943869 Apr 27, 2020 (154)
123 EVA ss3825864195 Apr 27, 2020 (154)
124 EVA ss3834329332 Apr 27, 2020 (154)
125 EVA ss3840764283 Apr 27, 2020 (154)
126 EVA ss3846254272 Apr 27, 2020 (154)
127 HGDP ss3847529763 Apr 27, 2020 (154)
128 SGDP_PRJ ss3883314327 Apr 27, 2020 (154)
129 KRGDB ss3932543546 Apr 27, 2020 (154)
130 FSA-LAB ss3984078454 Apr 27, 2021 (155)
131 EVA ss3984704404 Apr 27, 2021 (155)
132 EVA ss3985728209 Apr 27, 2021 (155)
133 EVA ss3986658278 Apr 27, 2021 (155)
134 EVA ss4017711881 Apr 27, 2021 (155)
135 TOPMED ss4998155695 Apr 27, 2021 (155)
136 TOMMO_GENOMICS ss5217094841 Apr 27, 2021 (155)
137 EVA ss5236926100 Apr 27, 2021 (155)
138 EVA ss5237231094 Apr 27, 2021 (155)
139 EVA ss5237664546 Oct 16, 2022 (156)
140 1000G_HIGH_COVERAGE ss5299113882 Oct 16, 2022 (156)
141 TRAN_CS_UWATERLOO ss5314441853 Oct 16, 2022 (156)
142 EVA ss5315798761 Oct 16, 2022 (156)
143 EVA ss5420470261 Oct 16, 2022 (156)
144 HUGCELL_USP ss5492771652 Oct 16, 2022 (156)
145 EVA ss5511491017 Oct 16, 2022 (156)
146 1000G_HIGH_COVERAGE ss5600853259 Oct 16, 2022 (156)
147 EVA ss5623965160 Oct 16, 2022 (156)
148 EVA ss5624055494 Oct 16, 2022 (156)
149 SANFORD_IMAGENETICS ss5624365874 Oct 16, 2022 (156)
150 SANFORD_IMAGENETICS ss5657887446 Oct 16, 2022 (156)
151 TOMMO_GENOMICS ss5771171130 Oct 16, 2022 (156)
152 EVA ss5799454419 Oct 16, 2022 (156)
153 EVA ss5799943162 Oct 16, 2022 (156)
154 EVA ss5800068445 Oct 16, 2022 (156)
155 EVA ss5800195304 Oct 16, 2022 (156)
156 YY_MCH ss5815502272 Oct 16, 2022 (156)
157 EVA ss5828461626 Oct 16, 2022 (156)
158 EVA ss5847750814 Oct 16, 2022 (156)
159 EVA ss5848408314 Oct 16, 2022 (156)
160 EVA ss5876651951 Oct 16, 2022 (156)
161 EVA ss5936561103 Oct 16, 2022 (156)
162 EVA ss5949305634 Oct 16, 2022 (156)
163 EVA ss5980883386 Oct 16, 2022 (156)
164 1000Genomes NC_000015.9 - 78894339 Oct 12, 2018 (152)
165 1000Genomes_30x NC_000015.10 - 78601997 Oct 16, 2022 (156)
166 The Avon Longitudinal Study of Parents and Children NC_000015.9 - 78894339 Oct 12, 2018 (152)
167 Genetic variation in the Estonian population NC_000015.9 - 78894339 Oct 12, 2018 (152)
168 ExAC NC_000015.9 - 78894339 Oct 12, 2018 (152)
169 FINRISK NC_000015.9 - 78894339 Apr 27, 2020 (154)
170 The Danish reference pan genome NC_000015.9 - 78894339 Apr 27, 2020 (154)
171 gnomAD - Genomes NC_000015.10 - 78601997 Apr 27, 2021 (155)
172 gnomAD - Exomes NC_000015.9 - 78894339 Jul 13, 2019 (153)
173 GO Exome Sequencing Project NC_000015.9 - 78894339 Oct 12, 2018 (152)
174 Genome of the Netherlands Release 5 NC_000015.9 - 78894339 Apr 27, 2020 (154)
175 HGDP-CEPH-db Supplement 1 NC_000015.8 - 76681394 Apr 27, 2020 (154)
176 HapMap NC_000015.10 - 78601997 Apr 27, 2020 (154)
177 KOREAN population from KRGDB NC_000015.9 - 78894339 Apr 27, 2020 (154)
178 Medical Genome Project healthy controls from Spanish population NC_000015.9 - 78894339 Apr 27, 2020 (154)
179 Northern Sweden NC_000015.9 - 78894339 Jul 13, 2019 (153)
180 The PAGE Study NC_000015.10 - 78601997 Jul 13, 2019 (153)
181 Ancient Sardinia genome-wide 1240k capture data generation and analysis NC_000015.9 - 78894339 Apr 27, 2021 (155)
182 CNV burdens in cranial meningiomas NC_000015.9 - 78894339 Apr 27, 2021 (155)
183 Qatari NC_000015.9 - 78894339 Apr 27, 2020 (154)
184 SGDP_PRJ NC_000015.9 - 78894339 Apr 27, 2020 (154)
185 Siberian NC_000015.9 - 78894339 Apr 27, 2020 (154)
186 8.3KJPN NC_000015.9 - 78894339 Apr 27, 2021 (155)
187 14KJPN NC_000015.10 - 78601997 Oct 16, 2022 (156)
188 TopMed NC_000015.10 - 78601997 Apr 27, 2021 (155)
189 UK 10K study - Twins NC_000015.9 - 78894339 Oct 12, 2018 (152)
190 ALFA NC_000015.10 - 78601997 Apr 27, 2021 (155)
191 ClinVar RCV000019055.3 Oct 16, 2022 (156)
192 ClinVar RCV000033204.3 Oct 16, 2022 (156)
Help

History tab displays RefSNPs (Associated ID) from previous builds (Build) that now support the current RefSNP, and the dates, when the history was updated for each Associated ID (History Updated).

Associated ID History Updated (Build)
rs17486992 Oct 08, 2004 (123)
rs59313803 May 25, 2008 (130)
rs117683679 Aug 16, 2010 (132)
rs386514167 Aug 21, 2014 (142)
Added to this RefSNP Cluster:
Submission IDs Observation SPDI Canonical SPDI Source RSIDs
207655, ss108966814, ss207219787, ss255132764, ss286987132, ss410887974, ss479312924, ss491249729, ss491705171, ss825345086, ss1696008199, ss1713504257, ss2635059730, ss3639061033, ss3639536015, ss3643080479, ss3847529763 NC_000015.8:76681393:G:A NC_000015.10:78601996:G:A (self)
67330637, 37389944, 26473691, 2331565, 91990, 3933787, 10702652, 1401117, 16684419, 39720940, 521559, 14372467, 954136, 253929, 17427063, 35331307, 9399047, 75064148, 37389944, ss226987927, ss236845753, ss243220619, ss342409746, ss479316024, ss479700326, ss484456772, ss491088657, ss491497937, ss536622098, ss564593482, ss660330994, ss778360901, ss782674941, ss783643607, ss831925656, ss832648157, ss833238846, ss833815674, ss974492212, ss991981992, ss1067554683, ss1080267011, ss1354231316, ss1427685769, ss1577713203, ss1584095529, ss1633409666, ss1676403699, ss1691948724, ss1711405799, ss1752172490, ss1935385133, ss1959628676, ss1968152663, ss2028474142, ss2094798443, ss2095060252, ss2156882693, ss2633253978, ss2701363292, ss2710821053, ss2741435479, ss2749362088, ss2937110693, ss2985047758, ss2985683920, ss3013594075, ss3021651901, ss3351199668, ss3625678966, ss3627406767, ss3631245082, ss3633103685, ss3633808613, ss3634616130, ss3635497383, ss3636306541, ss3637248695, ss3638097037, ss3640323451, ss3644652555, ss3646478153, ss3652053671, ss3653820045, ss3680735443, ss3741087602, ss3744916652, ss3753326002, ss3772415199, ss3824943869, ss3825864195, ss3834329332, ss3840764283, ss3883314327, ss3932543546, ss3984078454, ss3984704404, ss3985728209, ss3986658278, ss4017711881, ss5217094841, ss5315798761, ss5420470261, ss5511491017, ss5623965160, ss5624055494, ss5624365874, ss5657887446, ss5799454419, ss5799943162, ss5800068445, ss5800195304, ss5828461626, ss5847750814, ss5848408314, ss5936561103, ss5949305634, ss5980883386 NC_000015.9:78894338:G:A NC_000015.10:78601996:G:A (self)
RCV000019055.3, RCV000033204.3, 88379194, 474711113, 1299223, 1064985, 105008234, 213701355, 7448815897, ss1505810978, ss2208362371, ss3028061344, ss3698269901, ss3725516545, ss3771843516, ss3818629958, ss3846254272, ss4998155695, ss5236926100, ss5237231094, ss5237664546, ss5299113882, ss5314441853, ss5492771652, ss5600853259, ss5771171130, ss5815502272, ss5876651951 NC_000015.10:78601996:G:A NC_000015.10:78601996:G:A (self)
ss16686526 NT_010194.16:49684658:G:A NC_000015.10:78601996:G:A (self)
ss1527503, ss6752714, ss12586759, ss24450352, ss66633671, ss66894650, ss67002526, ss68382321, ss70375475, ss70490682, ss71015211, ss75505216, ss76901672, ss83674185, ss86272886, ss98336491, ss99307503, ss121363562, ss152786497, ss159135491, ss159731143, ss159908614, ss161151767, ss169545555, ss170343271, ss469414507, ss469415358, ss469996490 NT_010194.17:49684895:G:A NC_000015.10:78601996:G:A (self)
Help

Publications tab displays PubMed articles citing the variation as a listing of PMID, Title, Author, Year, Journal, ordered by Year, descending.

290 citations for rs1051730
PMID Title Author Year Journal
17135278 Cholinergic nicotinic receptor genes implicated in a nicotine dependence association study targeting 348 candidate genes with 3713 SNPs. Saccone SF et al. 2007 Human molecular genetics
18385676 Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1. Amos CI et al. 2008 Nature genetics
18385738 A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25. Hung RJ et al. 2008 Nature
18385739 A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Thorgeirsson TE et al. 2008 Nature
18414406 Genetic variation in the CHRNA5 gene affects mRNA levels and is associated with risk for alcohol dependence. Wang JC et al. 2009 Molecular psychiatry
18519524 Variants in nicotinic receptors and risk for nicotine dependence. Bierut LJ et al. 2008 The American journal of psychiatry
18565990 Systematic biological prioritization after a genome-wide association study: an application to nicotine dependence. Saccone SF et al. 2008 Bioinformatics (Oxford, England)
18571741 Genetic variability in nicotinic acetylcholine receptors and nicotine addiction: converging evidence from human and animal research. Portugal GS et al. 2008 Behavioural brain research
18618000 A candidate gene approach identifies the CHRNA5-A3-B4 region as a risk factor for age-dependent nicotine addiction. Weiss RB et al. 2008 PLoS genetics
18759969 In search of causal variants: refining disease association signals using cross-population contrasts. Saccone NL et al. 2008 BMC genetics
18780872 Familial aggregation of common sequence variants on 15q24-25.1 in lung cancer. Liu P et al. 2008 Journal of the National Cancer Institute
18957677 The CHRNA5-A3 region on chromosome 15q24-25.1 is a risk factor both for nicotine dependence and for lung cancer. Spitz MR et al. 2008 Journal of the National Cancer Institute
18978790 Lung cancer susceptibility locus at 5p15.33. McKay JD et al. 2008 Nature genetics
19005185 Contribution of nicotine acetylcholine receptor polymorphisms to lung cancer risk in a smoking-independent manner in the Japanese. Shiraishi K et al. 2009 Carcinogenesis
19010884 Smokers with the CHRNA lung cancer-associated variants are exposed to higher levels of nicotine equivalents and a carcinogenic tobacco-specific nitrosamine. Le Marchand L et al. 2008 Cancer research
19029397 Nicotinic receptor gene variants influence susceptibility to heavy smoking. Stevens VL et al. 2008 Cancer epidemiology, biomarkers & prevention
19064933 Chromosome 15q25.1 genetic markers associated with level of response to alcohol in humans. Joslyn G et al. 2008 Proceedings of the National Academy of Sciences of the United States of America
19132693 Variants in nicotinic acetylcholine receptors alpha5 and alpha3 increase risks to nicotine dependence. Chen X et al. 2009 American journal of medical genetics. Part B, Neuropsychiatric genetics
19247474 Genome-wide and candidate gene association study of cigarette smoking behaviors. Caporaso N et al. 2009 PloS one
19259974 Multiple distinct risk loci for nicotine dependence identified by dense coverage of the complete family of nicotinic receptor subunit (CHRN) genes. Saccone NL et al. 2009 American journal of medical genetics. Part B, Neuropsychiatric genetics
19300482 A genome-wide association study in chronic obstructive pulmonary disease (COPD): identification of two major susceptibility loci. Pillai SG et al. 2009 PLoS genetics
19300500 A genome-wide association study of pulmonary function measures in the Framingham Heart Study. Wilk JB et al. 2009 PLoS genetics
19423719 Update in lung cancer 2008. Dubey S et al. 2009 American journal of respiratory and critical care medicine
19429911 A common genetic variant in the 15q24 nicotinic acetylcholine receptor gene cluster (CHRNA5-CHRNA3-CHRNB4) is associated with a reduced ability of women to quit smoking in pregnancy. Freathy RM et al. 2009 Human molecular genetics
19436041 Human neuronal acetylcholine receptor A5-A3-B4 haplotypes are associated with multiple nicotine dependence phenotypes. Baker TB et al. 2009 Nicotine & tobacco research
19443489 Risk for nicotine dependence and lung cancer is conferred by mRNA expression levels and amino acid change in CHRNA5. Wang JC et al. 2009 Human molecular genetics
19465454 The TERT-CLPTM1L lung cancer susceptibility variant associates with higher DNA adduct formation in the lung. Zienolddiny S et al. 2009 Carcinogenesis
19494806 Dopamine genes and nicotine dependence in treatment-seeking and community smokers. Bergen AW et al. 2009 Neuropsychopharmacology
19569043 Genome-wide association studies and the genetic dissection of complex traits. Sebastiani P et al. 2009 American journal of hematology
19628476 Association of serum cotinine level with a cluster of three nicotinic acetylcholine receptor genes (CHRNA3/CHRNA5/CHRNB4) on chromosome 15. Keskitalo K et al. 2009 Human molecular genetics
19639606 Correcting "winner's curse" in odds ratios from genomewide association findings for major complex human diseases. Zhong H et al. 2010 Genetic epidemiology
19641473 Racial differences in the association between SNPs on 15q25.1, smoking behavior, and risk of non-small cell lung cancer. Schwartz AG et al. 2009 Journal of thoracic oncology
19706762 The CHRNA5-CHRNA3-CHRNB4 nicotinic receptor subunit gene cluster affects risk for nicotine dependence in African-Americans and in European-Americans. Saccone NL et al. 2009 Cancer research
19733931 Blood-based CHRNA3 single nucleotide polymorphism and outcome in advanced non-small-cell lung cancer patients. Carcereny E et al. 2010 Lung cancer (Amsterdam, Netherlands)
19741265 Genetics and genomics of chronic obstructive pulmonary disease. Silverman EK et al. 2009 Proceedings of the American Thoracic Society
19750184 Genome-wide association studies for atherosclerotic vascular disease and its risk factors. Ding K et al. 2009 Circulation. Cardiovascular genetics
19800047 Integration of genomic and genetic approaches implicates IREB2 as a COPD susceptibility gene. DeMeo DL et al. 2009 American journal of human genetics
19836008 A genome-wide association study of lung cancer identifies a region of chromosome 5p15 associated with risk for adenocarcinoma. Landi MT et al. 2009 American journal of human genetics
19859904 Association and interaction analysis of variants in CHRNA5/CHRNA3/CHRNB4 gene cluster with nicotine dependence in African and European Americans. Li MD et al. 2010 American journal of medical genetics. Part B, Neuropsychiatric genetics
19903803 Re: Discriminatory accuracy from single-nucleotide polymorphisms in models to predict breast cancer risk. Spitz MR et al. 2009 Journal of the National Cancer Institute
19951401 Chronic obstructive pulmonary disease: towards pharmacogenetics. Wood AM et al. 2009 Genome medicine
20007924 The 15q24/25 susceptibility variant for lung cancer and chronic obstructive pulmonary disease is associated with emphysema. Lambrechts D et al. 2010 American journal of respiratory and critical care medicine
20010834 Genome-wide association study identifies five loci associated with lung function. Repapi E et al. 2010 Nature genetics
20010835 Meta-analyses of genome-wide association studies identify multiple loci associated with pulmonary function. Hancock DB et al. 2010 Nature genetics
20068085 Analysis of genetic variants in never-smokers with lung cancer facilitated by an Internet-based blood collection protocol: a preliminary report. Girard N et al. 2010 Clinical cancer research
20142248 Cumulative effect of multiple loci on genetic susceptibility to familial lung cancer. Liu P et al. 2010 Cancer epidemiology, biomarkers & prevention
20147892 Convergent evidence that choline acetyltransferase gene variation is associated with prospective smoking cessation and nicotine dependence. Ray R et al. 2010 Neuropsychopharmacology
20158304 A genomewide association study of nicotine and alcohol dependence in Australian and Dutch populations. Lind PA et al. 2010 Twin research and human genetics
20159342 Genetics of addictions. Hartz SM et al. 2010 The Psychiatric clinics of North America
20348396 A general framework for studying genetic effects and gene-environment interactions with missing data. Hu YJ et al. 2010 Biostatistics (Oxford, England)
20393456 Sensorimotor gating is associated with CHRNA3 polymorphisms in schizophrenia and healthy volunteers. Petrovsky N et al. 2010 Neuropsychopharmacology
20395203 A second genetic variant on chromosome 15q24-25.1 associates with lung cancer. Liu P et al. 2010 Cancer research
20418888 Sequence variants at CHRNB3-CHRNA6 and CYP2A6 affect smoking behavior. Thorgeirsson TE et al. 2010 Nature genetics
20418889 Meta-analysis and imputation refines the association of 15q25 with smoking quantity. Liu JZ et al. 2010 Nature genetics
20418890 Genome-wide meta-analyses identify multiple loci associated with smoking behavior. 2010 Nature genetics
20485328 Variation in nicotinic acetylcholine receptor genes is associated with multiple substance dependence phenotypes. Sherva R et al. 2010 Neuropsychopharmacology
20548021 Replication of lung cancer susceptibility loci at chromosomes 15q25, 5p15, and 6p21: a pooled analysis from the International Lung Cancer Consortium. Truong T et al. 2010 Journal of the National Cancer Institute
20554942 Nicotinic acetylcholine receptor region on chromosome 15q25 and lung cancer risk among African Americans: a case-control study. Amos CI et al. 2010 Journal of the National Cancer Institute
20564069 Mediating effects of smoking and chronic obstructive pulmonary disease on the relation between the CHRNA5-A3 genetic locus and lung cancer risk. Wang J et al. 2010 Cancer
20581870 From smoking to lung cancer: the CHRNA5/A3/B4 connection. Improgo MR et al. 2010 Oncogene
20585100 Genome-wide association studies of cancer. Stadler ZK et al. 2010 Journal of clinical oncology
20631687 Variation in the nicotinic acetylcholine receptor gene cluster CHRNA5-CHRNA3-CHRNB4 and its interaction with recent tobacco use influence cognitive flexibility. Zhang H et al. 2010 Neuropsychopharmacology
20643934 A genetically modulated, intrinsic cingulate circuit supports human nicotine addiction. Hong LE et al. 2010 Proceedings of the National Academy of Sciences of the United States of America
20656943 Loci identified by genome-wide association studies influence different disease-related phenotypes in chronic obstructive pulmonary disease. Pillai SG et al. 2010 American journal of respiratory and critical care medicine
20700436 Multiple independent loci at chromosome 15q25.1 affect smoking quantity: a meta-analysis and comparison with lung cancer and COPD. Saccone NL et al. 2010 PLoS genetics
20736995 Resequencing of nicotinic acetylcholine receptor genes and association of common and rare variants with the Fagerström test for nicotine dependence. Wessel J et al. 2010 Neuropsychopharmacology
20808433 Associations of variants in CHRNA5/A3/B4 gene cluster with smoking behaviors in a Korean population. Li MD et al. 2010 PloS one
20832656 Genetics of addictions. Hartz SM et al. 2010 Clinics in laboratory medicine
20886544 Risk gene variants for nicotine dependence in the CHRNA5-CHRNA3-CHRNB4 cluster are associated with cognitive performance. Winterer G et al. 2010 American journal of medical genetics. Part B, Neuropsychiatric genetics
21079997 Uncovering hidden variance: pair-wise SNP analysis accounts for additional variance in nicotine dependence. Culverhouse RC et al. 2011 Human genetics
21081471 Genetic variations on chromosomes 5p15 and 15q25 and bladder cancer risk: findings from the Los Angeles-Shanghai bladder case-control study. Gago-Dominguez M et al. 2011 Carcinogenesis
21168125 TTC12-ANKK1-DRD2 and CHRNA5-CHRNA3-CHRNB4 influence different pathways leading to smoking behavior from adolescence to mid-adulthood. Ducci F et al. 2011 Biological psychiatry
21191315 Genetic association of bipolar disorder with the β(3) nicotinic receptor subunit gene. Hartz SM et al. 2011 Psychiatric genetics
21219822 [Recent progress in genetic variants associated with cancer and their implications in diagnostics development]. Cho WC et al. 2011 Zhongguo fei ai za zhi = Chinese journal of lung cancer
21228559 An exploratory study on the CHRNA3-CHRNA5-CHRNB4 cluster, smoking, and Parkinson's disease. Gao J et al. 2011 Neuro-degenerative diseases
21229299 Chromosome 15q24-25.1 variants, diet, and lung cancer susceptibility in cigarette smokers. Sakoda LC et al. 2011 Cancer causes & control
21232152 Epidemiology, radiology, and genetics of nicotine dependence in COPD. Kim DK et al. 2011 Respiratory research
21248747 Association of a variant in the CHRNA5-A3-B4 gene cluster region to heavy smoking in the Italian population. Sorice R et al. 2011 European journal of human genetics
21268243 Markers in the 15q24 nicotinic receptor subunit gene cluster (CHRNA5-A3-B4) predict severity of nicotine addiction and response to smoking cessation therapy. Sarginson JE et al. 2011 American journal of medical genetics. Part B, Neuropsychiatric genetics
21296624 An analysis of single nucleotide polymorphisms of 125 DNA repair genes in the Texas genome-wide association study of lung cancer with a replication for the XRCC4 SNPs. Yu H et al. 2011 DNA repair
21320324 The role of IREB2 and transforming growth factor beta-1 genetic variants in COPD: a replication case-control study. Chappell SL et al. 2011 BMC medical genetics
21357676 Sequence variants at CYP1A1-CYP1A2 and AHR associate with coffee consumption. Sulem P et al. 2011 Human molecular genetics
21385908 Association of the nicotine metabolite ratio and CHRNA5/CHRNA3 polymorphisms with smoking rate among treatment-seeking smokers. Falcone M et al. 2011 Nicotine & tobacco research
21424681 Peripheral arterial disease in diabetes: is there a role for genetics? Katwal AB et al. 2011 Current diabetes reports
21430647 The galanin receptor 1 gene associates with tobacco craving in smokers seeking cessation treatment. Lori A et al. 2011 Neuropsychopharmacology
21436384 Genetic variability of smoking persistence in African Americans. Hamidovic A et al. 2011 Cancer prevention research (Philadelphia, Pa.)
21438146 Dysfunctional gene splicing as a potential contributor to neuropsychiatric disorders. Glatt SJ et al. 2011 American journal of medical genetics. Part B, Neuropsychiatric genetics
21498873 Associations of nicotine intake measures with CHRN genes in Finnish smokers. Keskitalo-Vuokko K et al. 2011 Nicotine & tobacco research
21559498 Chromosome 15q25 (CHRNA3-CHRNA5) variation impacts indirectly on lung cancer risk. Wang Y et al. 2011 PloS one
21593077 Genetic variation at CHRNA5-CHRNA3-CHRNB4 interacts with smoking status to influence body mass index. Freathy RM et al. 2011 International journal of epidemiology
21606948 Varenicline for smoking cessation: nausea severity and variation in nicotinic receptor genes. Swan GE et al. 2012 The pharmacogenomics journal
21645942 Association of smoking with tumor size at diagnosis in non-small cell lung cancer. Chen X et al. 2011 Lung cancer (Amsterdam, Netherlands)
21646606 Nicotinic acetylcholine receptor polymorphism, smoking behavior, and tobacco-related cancer and lung and cardiovascular diseases: a cohort study. Kaur-Knudsen D et al. 2011 Journal of clinical oncology
21685187 Genome-wide association study of smoking behaviours in patients with COPD. Siedlinski M et al. 2011 Thorax
21690317 CHRNA3 rs1051730 genotype and short-term smoking cessation. Munafò MR et al. 2011 Nicotine & tobacco research
21697764 Susceptibility locus for lung cancer at 15q25.1 is not associated with risk of pancreatic cancer. Chen J et al. 2011 Pancreas
21747048 Relationship between CYP2A6 and CHRNA5-CHRNA3-CHRNB4 variation and smoking behaviors and lung cancer risk. Wassenaar CA et al. 2011 Journal of the National Cancer Institute
21748402 A twin association study of nicotine dependence with markers in the CHRNA3 and CHRNA5 genes. Maes HH et al. 2011 Behavior genetics
21808284 Gender-stratified gene and gene-treatment interactions in smoking cessation. Lee W et al. 2012 The pharmacogenomics journal
21858091 In vitro and ex vivo analysis of CHRNA3 and CHRNA5 haplotype expression. Doyle GA et al. 2011 PloS one
21921092 Identification of FGF7 as a novel susceptibility locus for chronic obstructive pulmonary disease. Brehm JM et al. 2011 Thorax
21949713 Genetics of sputum gene expression in chronic obstructive pulmonary disease. Qiu W et al. 2011 PloS one
22024417 Smoking and body weight: evidence using genetic instruments. Wehby GL et al. 2012 Economics and human biology
22071378 Association of the CHRNA5-A3-B4 gene cluster with heaviness of smoking: a meta-analysis. Ware JJ et al. 2011 Nicotine & tobacco research
22080838 A genome-wide association study of COPD identifies a susceptibility locus on chromosome 19q13. Cho MH et al. 2012 Human molecular genetics
22102629 Dissection of the phenotypic and genotypic associations with nicotinic dependence. Chen LS et al. 2012 Nicotine & tobacco research
22102793 GENES AS INSTRUMENTS FOR STUDYING RISK BEHAVIOR EFFECTS: AN APPLICATION TO MATERNAL SMOKING AND OROFACIAL CLEFTS. Wehby G et al. 2011 Health services & outcomes research methodology
22148122 A missense polymorphism (rs11895564, Ala380Thr) of integrin alpha 6 is associated with the development and progression of papillary thyroid carcinoma in Korean population. Kim SK et al. 2011 Journal of the Korean Surgical Society
22176972 Nicotinic acetylcholine receptor variants associated with susceptibility to chronic obstructive pulmonary disease: a meta-analysis. Zhang J et al. 2011 Respiratory research
22223462 Alpha-5 and -3 nicotinic receptor gene variants predict nicotine dependence but not cessation: findings from the COMMIT cohort. Bousman CA et al. 2012 American journal of medical genetics. Part B, Neuropsychiatric genetics
22241830 Analysis of detailed phenotype profiles reveals CHRNA5-CHRNA3-CHRNB4 gene cluster association with several nicotine dependence traits. Broms U et al. 2012 Nicotine & tobacco research
22280835 New associations of the genetic polymorphisms in nicotinic receptor genes with the risk of lung cancer. Chikova A et al. 2012 Life sciences
22281715 Recent advances in the genetic epidemiology and molecular genetics of substance use disorders. Kendler KS et al. 2012 Nature neuroscience
22290489 Pharmacogenetics of smoking cessation: role of nicotine target and metabolism genes. Gold AB et al. 2012 Human genetics
22301922 Measuring alcohol consumption for genomic meta-analyses of alcohol intake: opportunities and challenges. Agrawal A et al. 2012 The American journal of clinical nutrition
22356581 Association of IREB2 and CHRNA3 polymorphisms with airflow obstruction in severe alpha-1 antitrypsin deficiency. Kim WJ et al. 2012 Respiratory research
22382757 The CHRNA5/A3/B4 gene cluster and tobacco, alcohol, cannabis, inhalants and other substance use initiation: replication and new findings using mixture analyses. Lubke GH et al. 2012 Behavior genetics
22438921 Nicotinic acetylcholine receptor variants are related to smoking habits, but not directly to COPD. Budulac SE et al. 2012 PloS one
22438940 Variants located upstream of CHRNB4 on chromosome 15q25.1 are associated with age at onset of daily smoking and habitual smoking. Kapoor M et al. 2012 PloS one
22441734 CHRNA3 genotype, nicotine dependence, lung function and disease in the general population. Kaur-Knudsen D et al. 2012 The European respiratory journal
22461431 CHRNA3/5, IREB2, and ADCY2 are associated with severe chronic obstructive pulmonary disease in Poland. Hardin M et al. 2012 American journal of respiratory cell and molecular biology
22492058 A common genetic network underlies substance use disorders and disruptive or externalizing disorders. Arcos-Burgos M et al. 2012 Human genetics
22495174 DRD1 associations with smoking abstinence across slow and normal nicotine metabolizers. Lee W et al. 2012 Pharmacogenetics and genomics
22510351 Defining a gene promoter methylation signature in sputum for lung cancer risk assessment. Leng S et al. 2012 Clinical cancer research
22534784 Association between genetic variants on chromosome 15q25 locus and objective measures of tobacco exposure. Munafò MR et al. 2012 Journal of the National Cancer Institute
22539395 Smoking and genetic risk variation across populations of European, Asian, and African American ancestry--a meta-analysis of chromosome 15q25. Chen LS et al. 2012 Genetic epidemiology
22544838 From men to mice: CHRNA5/CHRNA3, smoking behavior and disease. Ware JJ et al. 2012 Nicotine & tobacco research
22586632 Variants in inflammation genes are implicated in risk of lung cancer in never smokers exposed to second-hand smoke. Spitz MR et al. 2011 Cancer discovery
22640768 The genetic basis of addictive disorders. Ducci F et al. 2012 The Psychiatric clinics of North America
22648373 Interplay of genetic risk factors (CHRNA5-CHRNA3-CHRNB4) and cessation treatments in smoking cessation success. Chen LS et al. 2012 The American journal of psychiatry
22662130 Using prior information from the medical literature in GWAS of oral cancer identifies novel susceptibility variant on chromosome 4--the AdAPT method. Johansson M et al. 2012 PloS one
22687325 The causal role of smoking in anxiety and depression: a Mendelian randomization analysis of the HUNT study. Bjørngaard JH et al. 2013 Psychological medicine
22701590 Strong association between two polymorphisms on 15q25.1 and lung cancer risk: a meta-analysis. Gu M et al. 2012 PloS one
22793939 Genes and chronic obstructive pulmonary disease. Foreman MG et al. 2012 The Medical clinics of North America
22806211 The genetics of addiction-a translational perspective. Agrawal A et al. 2012 Translational psychiatry
22832964 Genome-wide meta-analyses of smoking behaviors in African Americans. David SP et al. 2012 Translational psychiatry
22837378 Genome-wide association studies identify CHRNA5/3 and HTR4 in the development of airflow obstruction. Wilk JB et al. 2012 American journal of respiratory and critical care medicine
22854838 The influence of race and ethnicity on the biology of cancer. Henderson BE et al. 2012 Nature reviews. Cancer
22899653 Influence of common genetic variation on lung cancer risk: meta-analysis of 14 900 cases and 29 485 controls. Timofeeva MN et al. 2012 Human molecular genetics
22914670 Association of IREB2 and CHRNA3/5 polymorphisms with COPD and COPD-related phenotypes in a Chinese Han population. Zhou H et al. 2012 Journal of human genetics
22945651 Epigenetic screen identifies genotype-specific promoter DNA methylation and oncogenic potential of CHRNB4. Scherf DB et al. 2013 Oncogene
22956269 Genetic variation in the 15q25 nicotinic acetylcholine receptor gene cluster (CHRNA5-CHRNA3-CHRNB4) interacts with maternal self-reported smoking status during pregnancy to influence birth weight. Tyrrell J et al. 2012 Human molecular genetics
22992668 Pharmacogenomics knowledge for personalized medicine. Whirl-Carrillo M et al. 2012 Clinical pharmacology and therapeutics
23024249 Development of novel pharmacotherapeutics for tobacco dependence: progress and future directions. Harmey D et al. 2012 Nicotine & tobacco research
23027417 Nicotinic mechanisms in the treatment of psychotic disorders: a focus on the α7 nicotinic receptor. Olincy A et al. 2012 Handbook of experimental pharmacology
23028716 Association test based on SNP set: logistic kernel machine based test vs. principal component analysis. Zhao Y et al. 2012 PloS one
23029550 Associations between variation in CHRNA5-CHRNA3-CHRNB4, body mass index and blood pressure in the Northern Finland Birth Cohort 1966. Kaakinen M et al. 2012 PloS one
23055711 Updates on the COPD gene list. Bossé Y et al. 2012 International journal of chronic obstructive pulmonary disease
23056235 Functional polymorphisms of CHRNA3 predict risks of chronic obstructive pulmonary disease and lung cancer in Chinese. Yang L et al. 2012 PloS one
23070629 Demethylation of the aryl hydrocarbon receptor repressor as a biomarker for nascent smokers. Philibert RA et al. 2012 Epigenetics
23090857 Emerging genetics of COPD. Berndt A et al. 2012 EMBO molecular medicine
23143843 Molecular mechanisms underlying behaviors related to nicotine addiction. Picciotto MR et al. 2013 Cold Spring Harbor perspectives in medicine
23196875 Variants in the 15q25 gene cluster are associated with risk for schizophrenia and bipolar disorder. Jackson KJ et al. 2013 Psychiatric genetics
23221128 Fine-mapping of the 5p15.33, 6p22.1-p21.31, and 15q25.1 regions identifies functional and histology-specific lung cancer susceptibility loci in African-Americans. Walsh KM et al. 2013 Cancer epidemiology, biomarkers & prevention
23228068 Prediction of lung cancer risk in a Chinese population using a multifactorial genetic model. Li H et al. 2012 BMC medical genetics
23249876 Nicotinic acetylcholine receptor variation and response to smoking cessation therapies. Bergen AW et al. 2013 Pharmacogenetics and genomics
23255854 A functional polymorphism in the CHRNA3 gene and risk of chronic obstructive pulmonary disease in a Korean population. Lee JY et al. 2012 Journal of Korean medical science
23267696 Association of genetic polymorphisms with chronic obstructive pulmonary disease in the Chinese Han population: a case-control study. Guo Y et al. 2012 BMC medical genomics
23299987 Dissecting direct and indirect genetic effects on chronic obstructive pulmonary disease (COPD) susceptibility. Siedlinski M et al. 2013 Human genetics
23334941 A bivariate mann-whitney approach for unraveling genetic variants and interactions contributing to comorbidity. Wen Y et al. 2013 Genetic epidemiology
23349013 Genetic susceptibility to lung cancer--light at the end of the tunnel? Marshall AL et al. 2013 Carcinogenesis
23349703 Variants in the 15q24/25 locus associate with lung function decline in active smokers. Mohamed Hoesein FA et al. 2013 PloS one
23358500 Variation in the α 5 nicotinic acetylcholine receptor subunit gene predicts cigarette smoking intensity as a function of nicotine content. Macqueen DA et al. 2014 The pharmacogenomics journal
23397474 Polymorphisms of CHRNA5-CHRNA3-CHRNB4 Gene Cluster and NSCLC Risk in Chinese Population. Li Z et al. 2012 Translational oncology
23408875 Getting more out of biomedical documents with GATE's full lifecycle open source text analytics. Cunningham H et al. 2013 PLoS computational biology
23429840 Prepulse inhibition of startle response: recent advances in human studies of psychiatric disease. Takahashi H et al. 2011 Clinical psychopharmacology and neuroscience
23454887 Role of selected genetic variants in lung cancer risk in African Americans. Spitz MR et al. 2013 Journal of thoracic oncology
23536134 Polygenic risk and the developmental progression to heavy, persistent smoking and nicotine dependence: evidence from a 4-decade longitudinal study. Belsky DW et al. 2013 JAMA psychiatry
23565320 DNA repair genotype and lung cancer risk in the beta-carotene and retinol efficacy trial. Doherty JA et al. 2013 International journal of molecular epidemiology and genetics
23588313 Biomarkers for smoking cessation. Bough KJ et al. 2013 Clinical pharmacology and therapeutics
23604333 The effect of nicotine on sensorimotor gating is modulated by a CHRNA3 polymorphism. Petrovsky N et al. 2013 Psychopharmacology
23689675 Genetic risk for nicotine dependence in the cholinergic system and activation of the brain reward system in healthy adolescents. Nees F et al. 2013 Neuropsychopharmacology
23691092 Associations of prenatal nicotine exposure and the dopamine related genes ANKK1 and DRD2 to verbal language. Eicher JD et al. 2013 PloS one
23692359 CHRNA5-A3-B4 genetic variants alter nicotine intake and interact with tobacco use to influence body weight in Alaska Native tobacco users. Zhu AZ et al. 2013 Addiction (Abingdon, England)
23701534 Genetic instrumental variable studies of effects of prenatal risk factors. Wehby GL et al. 2013 Biodemography and social biology
23820649 Where genotype is not predictive of phenotype: towards an understanding of the molecular basis of reduced penetrance in human inherited disease. Cooper DN et al. 2013 Human genetics
23844051 Association of CHRNA5-A3-B4 variation with esophageal squamous cell carcinoma risk and smoking behaviors in a Chinese population. Wang Y et al. 2013 PloS one
23847157 Using Mendelian randomisation to infer causality in depression and anxiety research. Gage SH et al. 2013 Depression and anxiety
23872218 Functional characterization of SNPs in CHRNA3/B4 intergenic region associated with drug behaviors. Flora AV et al. 2013 Brain research
23875064 Scrutiny of the CHRNA5-CHRNA3-CHRNB4 smoking behavior locus reveals a novel association with alcohol use in a Finnish population based study. Hällfors J et al. 2013 International journal of molecular epidemiology and genetics
23942621 Interaction between polygenic risk for cigarette use and environmental exposures in the Detroit Neighborhood Health Study. Meyers JL et al. 2013 Translational psychiatry
23942779 A genome-wide association study of behavioral disinhibition. McGue M et al. 2013 Behavior genetics
23943838 Effect of neuronal nicotinic acetylcholine receptor genes (CHRN) on longitudinal cigarettes per day in adolescents and young adults. Cannon DS et al. 2014 Nicotine & tobacco research
24055496 A glimpse into the future - Personalized medicine for smoking cessation. Bierut LJ et al. 2014 Neuropharmacology
24065931 The CHRNA3 rs578776 Variant is Associated with an Intrinsic Reward Sensitivity Deficit in Smokers. Robinson JD et al. 2013 Frontiers in psychiatry
24084939 A common biological basis of obesity and nicotine addiction. Thorgeirsson TE et al. 2013 Translational psychiatry
24254305 Quantitative assessment of the influence of common variations (rs8034191 and rs1051730) at 15q25 and lung cancer risk. Hu B et al. 2014 Tumour biology
24337855 Association between CHRNA3 rs1051730 genotype and lung cancer risk in Chinese Han population: a case-control study. Ren JH et al. 2013 Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban
24388127 Mendelian randomization in health research: using appropriate genetic variants and avoiding biased estimates. Taylor AE et al. 2014 Economics and human biology
24521169 Maternal smoking during pregnancy and offspring smoking initiation: assessing the role of intrauterine exposure. Taylor AE et al. 2014 Addiction (Abingdon, England)
24535486 CHRNA3 and CYP3A5*3 genotype, lung function and chronic obstructive pulmonary disease in the general population. Kaur-Knudsen D et al. 2014 Pharmacogenetics and genomics
24572595 Characterizing the genetic basis of methylome diversity in histologically normal human lung tissue. Shi J et al. 2014 Nature communications
24588897 CHRNA5 and CHRNA3 variants and level of neuroticism in young adult Mexican American men and women. Criado JR et al. 2014 Twin research and human genetics
24667010 Nicotine dependence as a moderator of genetic influences on smoking cessation treatment outcome. Leventhal AM et al. 2014 Drug and alcohol dependence
24686516 CHRNA3 polymorphism modifies lung adenocarcinoma risk in the Chinese Han population. He P et al. 2014 International journal of molecular sciences
24688116 Genome-wide association meta-analysis of human longevity identifies a novel locus conferring survival beyond 90 years of age. Deelen J et al. 2014 Human molecular genetics
24778978 Genetics and smoking. Loukola A et al. 2014 Current addiction reports
24786987 Whole exome re-sequencing implicates CCDC38 and cilia structure and function in resistance to smoking related airflow obstruction. Wain LV et al. 2014 PLoS genetics
24867305 Causal associations of tobacco smoking with cardiovascular risk factors: a Mendelian randomization analysis of the HUNT Study in Norway. Åsvold BO et al. 2014 International journal of epidemiology
24906368 High tobacco consumption is causally associated with increased all-cause mortality in a general population sample of 55,568 individuals, but not with short telomeres: a Mendelian randomization study. Rode L et al. 2014 International journal of epidemiology
25009551 The ATXN2-SH2B3 locus is associated with peripheral arterial disease: an electronic medical record-based genome-wide association study. Kullo IJ et al. 2014 Frontiers in genetics
25036316 Joint association of nicotinic acetylcholine receptor variants with abdominal obesity in American Indians: the Strong Heart Family Study. Zhu Y et al. 2014 PloS one
25045619 The Genetics, Neurogenetics and Pharmacogenetics of Addiction. Demers CH et al. 2014 Current behavioral neuroscience reports
25051068 Four SNPs in the CHRNA3/5 alpha-neuronal nicotinic acetylcholine receptor subunit locus are associated with COPD risk based on meta-analyses. Cui K et al. 2014 PloS one
25174004 Genetic variability in the regulation of gene expression in ten regions of the human brain. Ramasamy A et al. 2014 Nature neuroscience
25214750 Genomics and personalized medicine: CHRNA5-CHRNA3-CHRNB4 and smoking cessation treatment. Chen LS et al. 2013 Journal of food and drug analysis
25233467 Role of nicotine dependence on the relationship between variants in the nicotinic receptor genes and risk of lung adenocarcinoma. Tseng TS et al. 2014 PloS one
25288178 The association between the rs6495309 polymorphism in CHRNA3 gene and lung cancer risk in Chinese: a meta-analysis. Xiao M et al. 2014 Scientific reports
25293386 Investigating the possible causal association of smoking with depression and anxiety using Mendelian randomisation meta-analysis: the CARTA consortium. Taylor AE et al. 2014 BMJ open
25302169 Acetylcholine receptor pathway in lung cancer: New twists to an old story. Niu XM et al. 2014 World journal of clinical oncology
25329654 Role of a genetic variant on the 15q25.1 lung cancer susceptibility locus in smoking-associated nasopharyngeal carcinoma. Ji X et al. 2014 PloS one
25471942 Contribution of Variants in CHRNA5/A3/B4 Gene Cluster on Chromosome 15 to Tobacco Smoking: From Genetic Association to Mechanism. Wen L et al. 2016 Molecular neurobiology
25474695 Stratification by smoking status reveals an association of CHRNA5-A3-B4 genotype with body mass index in never smokers. Taylor AE et al. 2014 PLoS genetics
25555385 Nicotine Dependence, Nicotine Metabolism, and the Extent of Compensation in Response to Reduced Nicotine Content Cigarettes. Bandiera FC et al. 2015 Nicotine & tobacco research
25632390 Association between genetic variants on chromosome 15q25 locus and several nicotine dependence traits in Polish population: a case-control study. Buczkowski K et al. 2015 BioMed research international
25642160 Nicotinic receptor modulation to treat alcohol and drug dependence. Rahman S et al. 2014 Frontiers in neuroscience
25658328 Polymorphism in the serotonin receptor 2a (HTR2A) gene as possible predisposal factor for aggressive traits. Banlaki Z et al. 2015 PloS one
25770649 Are genetic variants for tobacco smoking associated with cannabis involvement? Agrawal A et al. 2015 Drug and alcohol dependence
25777141 High tobacco consumption lowers body weight: a Mendelian randomization study of the Copenhagen General Population Study. Winsløw UC et al. 2015 International journal of epidemiology
25778907 The DYX2 locus and neurochemical signaling genes contribute to speech sound disorder and related neurocognitive domains. Eicher JD et al. 2015 Genes, brain, and behavior
25874685 CHRNA3 rs6495308 genotype as an effect modifier of the association between daily cigarette consumption and hypertension in Chinese male smokers. Wu XY et al. 2015 International journal of environmental research and public health
25891233 The association of rs1051730 genotype on adherence to and consumption of prescribed nicotine replacement therapy dose during a smoking cessation attempt. Ware JJ et al. 2015 Drug and alcohol dependence
26010901 Lack of Associations of CHRNA5-A3-B4 Genetic Variants with Smoking Cessation Treatment Outcomes in Caucasian Smokers despite Associations with Baseline Smoking. Tyndale RF et al. 2015 PloS one
26044620 Gene network analysis shows immune-signaling and ERK1/2 as novel genetic markers for multiple addiction phenotypes: alcohol, smoking and opioid addiction. Reyes-Gibby CC et al. 2015 BMC systems biology
26054357 Tobacco smoking is causally associated with antipsychotic medication use and schizophrenia, but not with antidepressant medication use or depression. Wium-Andersen MK et al. 2015 International journal of epidemiology
26079503 Associations between Potentially Modifiable Risk Factors and Alzheimer Disease: A Mendelian Randomization Study. Østergaard SD et al. 2015 PLoS medicine
26264275 Heavier smoking may lead to a relative increase in waist circumference: evidence for a causal relationship from a Mendelian randomisation meta-analysis. The CARTA consortium. Morris RW et al. 2015 BMJ open
26351737 Nicotinic acetylcholine receptors: upregulation, age-related effects and associations with drug use. Melroy-Greif WE et al. 2016 Genes, brain, and behavior
26508385 Analyzing large-scale samples confirms the association between the rs1051730 polymorphism and lung cancer susceptibility. Han Z et al. 2015 Scientific reports
26689306 Gene variance in the nicotinic receptor cluster (CHRNA5-CHRNA3-CHRNB4) predicts death from cardiopulmonary disease and cancer in smokers. Halldén S et al. 2016 Journal of internal medicine
26695521 Mendelian Randomization - the Key to Understanding Aspects of Parkinson's Disease Causation? Noyce AJ et al. 2016 Movement disorders
26751916 CHRNA5/CHRNA3 Locus Associates with Increased Mortality among Smokers. Kupiainen H et al. 2016 COPD
26831765 Association between two CHRNA3 variants and susceptibility of lung cancer: a meta-analysis. Qu X et al. 2016 Scientific reports
26833182 Genome-Wide Meta-Analysis of Cotinine Levels in Cigarette Smokers Identifies Locus at 4q13.2. Ware JJ et al. 2016 Scientific reports
26942719 Chromosome 15q25 (CHRNA3-CHRNB4) Variation Indirectly Impacts Lung Cancer Risk in Chinese Males. Zhang Y et al. 2016 PloS one
26948517 Genetic scores of smoking behaviour in a Chinese population. Yang S et al. 2016 Scientific reports
26961927 Best (but oft-forgotten) practices: the design, analysis, and interpretation of Mendelian randomization studies. Haycock PC et al. 2016 The American journal of clinical nutrition
26981122 The Oncogenic Functions of Nicotinic Acetylcholine Receptors. Zhao Y et al. 2016 Journal of oncology
26981579 Gene by Environment Investigation of Incident Lung Cancer Risk in African-Americans. David SP et al. 2016 EBioMedicine
27015805 Human longevity is influenced by many genetic variants: evidence from 75,000 UK Biobank participants. Pilling LC et al. 2016 Aging
27050379 Genetic variants of CHRNA5-A3 and CHRNB3-A6 predict survival of patients with advanced non-small cell lung cancer. Wang Y et al. 2016 Oncotarget
27127891 Association Between CHRNA3 and CHRNA5 Nicotine Receptor Subunit Gene Variants and Nicotine Dependence in an Isolated Populationof Kashubians in Poland. Kita-Milczarska K et al. 2016 Medical science monitor
27166759 Converging findings from linkage and association analyses on susceptibility genes for smoking and other addictions. Yang J et al. 2016 Molecular psychiatry
27230571 Different dietary patterns and reduction of lung cancer risk: A large case-control study in the U.S. Tu H et al. 2016 Scientific reports
27294413 Human genome meeting 2016 : Houston, TX, USA. 28 February - 2 March 2016. Srivastava AK et al. 2016 Human genomics
27335628 A prospective and retrospective analysis of smoking behavior changes in ever smokers with high risk for lung cancer from New Mexico and Pennsylvania. Leng S et al. 2016 International journal of molecular epidemiology and genetics
27613883 Does High Tobacco Consumption Cause Psychological Distress? A Mendelian Randomization Study. Skov-Ettrup LS et al. 2017 Nicotine & tobacco research
27663783 A Novel Tobacco Use Phenotype Suggests the 15q25 and 19q13 Loci May be Differentially Associated With Cigarettes per Day and Tobacco-Related Problems. Richmond-Rakerd LS et al. 2017 Nicotine & tobacco research
27694844 An Adaptive Fisher's Combination Method for Joint Analysis of Multiple Phenotypes in Association Studies. Liang X et al. 2016 Scientific reports
27805284 Susceptibility loci of CNOT6 in the general mRNA degradation pathway and lung cancer risk-A re-analysis of eight GWASs. Zhou F et al. 2017 Molecular carcinogenesis
27827986 Replicated Risk Nicotinic Cholinergic Receptor Genes for Nicotine Dependence. Zuo L et al. 2016 Genes
28049019 The causal role of smoking on the risk of hip or knee replacement due to primary osteoarthritis: a Mendelian randomisation analysis of the HUNT study. Johnsen MB et al. 2017 Osteoarthritis and cartilage
28388928 SNPPhenA: a corpus for extracting ranked associations of single-nucleotide polymorphisms and phenotypes from literature. Bokharaeian B et al. 2017 Journal of biomedical semantics
28474623 IREB2, CHRNA5, CHRNA3, FAM13A & hedgehog interacting protein genes polymorphisms & risk of chronic obstructive pulmonary disease in Tatar population from Russia. Korytina GF et al. 2016 The Indian journal of medical research
28533558 Investigating the causal effect of smoking on hay fever and asthma: a Mendelian randomization meta-analysis in the CARTA consortium. Skaaby T et al. 2017 Scientific reports
28884473 Pharmacotherapy for smoking cessation: effects by subgroup defined by genetically informed biomarkers. Schuit E et al. 2017 The Cochrane database of systematic reviews
29052254 Genetic polymorphisms associated with smoking behaviour predict the risk of surgery in patients with Crohn's disease. Lang BM et al. 2018 Alimentary pharmacology & therapeutics
29110844 Genetic polymorphisms and lung cancer risk: Evidence from meta-analyses and genome-wide association studies. Liu C et al. 2017 Lung cancer (Amsterdam, Netherlands)
29228387 Association Between rs1051730 and Smoking During Pregnancy in Dutch Women. Mbarek H et al. 2019 Nicotine & tobacco research
29509885 Is smoking heaviness causally associated with alcohol use? A Mendelian randomization study in four European cohorts. Taylor M et al. 2018 International journal of epidemiology
29609626 CHRNA5 and CHRNA3 polymorphism and lung cancer susceptibility in Palestinian population. Ayesh BM et al. 2018 BMC research notes
29621993 Cholinergic receptor nicotinic alpha 5 subunit polymorphisms are associated with smoking cessation success in women. Tomaz PRX et al. 2018 BMC medical genetics
29688528 Smoking, Systemic Inflammation, and Airflow Limitation: A Mendelian Randomization Analysis of 98 085 Individuals From the General Population. Çolak Y et al. 2019 Nicotine & tobacco research
29747220 The causal role of smoking on the risk of headache. A Mendelian randomization analysis in the HUNT study. Johnsen MB et al. 2018 European journal of neurology
29749891 The DRD2/ANKK1 Taq1A polymorphism is associated with smoking cessation failure in patients with coronary heart disease. Mayer O Jr et al. 2015 Personalized medicine
29942042 A decade in psychiatric GWAS research. Horwitz T et al. 2019 Molecular psychiatry
29974223 Causal association between smoking behavior and the decreased risk of osteoarthritis: a Mendelian randomization. Lee YH et al. 2019 Zeitschrift fur Rheumatologie
29993116 CHRNA3 rs1051730 and CHRNA5 rs16969968 polymorphisms are associated with heavy smoking, lung cancer, and chronic obstructive pulmonary disease in a mexican population. Pérez-Morales R et al. 2018 Annals of human genetics
30003442 Assessing the causal association between smoking behavior and risk of gout using a Mendelian randomization study. Lee YH et al. 2018 Clinical rheumatology
30060175 Whole exome sequencing analysis in severe chronic obstructive pulmonary disease. Qiao D et al. 2018 Human molecular genetics
30202916 Smoking Reduces Plasma Bilirubin: Observational and Genetic Analyses in the Copenhagen General Population Study. Kodal JB et al. 2020 Nicotine & tobacco research
30690475 Smoking Cessation Pharmacotherapy Based on Genetically-Informed Biomarkers: What is the Evidence? Panagiotou OA et al. 2019 Nicotine & tobacco research
30866659 Smoking and Increased White and Red Blood Cells. Pedersen KM et al. 2019 Arteriosclerosis, thrombosis, and vascular biology
31074779 The effect of smoking intensity on all-cause and cause-specific mortality-a Mendelian randomization analysis. Vie GÅ et al. 2019 International journal of epidemiology
31270413
31588985 [Analysis of polymorphism rs1051730 of CHRNA3 in patients with dual pathology in a Mexican population]. Genis-Mendoza A et al. 2019 Revista de neurologia
31721775 Associations of maternal quitting, reducing, and continuing smoking during pregnancy with longitudinal fetal growth: Findings from Mendelian randomization and parental negative control studies. Brand JS et al. 2019 PLoS medicine
31768164 Secular trends in smoking in relation to prevalent and incident smoking-related disease: A prospective population-based study. Tonnesen P et al. 2019 Tobacco induced diseases
31875952 Smoking, blood cells and myeloproliferative neoplasms: meta-analysis and Mendelian randomization of 2·3 million people. Jayasuriya NA et al. 2020 British journal of haematology
32022527 Synchronous and multiple renal cell carcinoma, clear cell and papillary: An approach to clinically significant genetic abnormalities. Cifuentes-C L et al. 2020 International braz j urol
32299301 Nicotinic acetylcholine receptors (rs1051730) gene polymorphism and surfactant protein D level in chronic obstructive pulmonary disease. El Gayed E et al. 2020 British journal of biomedical science
33173933 The Interplay between Maternal Smoking and Genes in Offspring Birth Weight. Pereira RD et al. 2020 medRxiv
33578531 The relationship between CHRNA5/A3/B4 gene cluster polymorphisms and lung cancer risk: An updated meta-analysis and systematic review. Yi X et al. 2021 Medicine
33710466 Cigarette Smoking Behavior a Gateway to Opium Use Disorder: A Mendelian Randomization Analysis. Rajabi A et al. 2021 Behavior genetics
34091767 Risk of ulcerative colitis and Crohn's disease in smokers lacks causal evidence. Pedersen KM et al. 2022 European journal of epidemiology
34522797 The effect of CHRNA3 rs1051730 C>T and ABCB1 rs3842 A>G polymorphisms on non-small cell lung cancer and nicotine dependence in Iranian population. Veiskarami P et al. 2021 Heliyon
34540891 Umbrella Review on Associations Between Single Nucleotide Polymorphisms and Lung Cancer Risk. Li X et al. 2021 Frontiers in molecular biosciences
34554350 A Gateway That Never Was. Vanyukov MM et al. 2022 Behavior genetics
35101137 Gene-gene interaction of AhRwith and within the Wntcascade affects susceptibility to lung cancer. Rosenberger A et al. 2022 European journal of medical research
36078193 Association of Polymorphism CHRNA5 and CHRNA3 Gene in People Addicted to Nicotine. Chmielowiec K et al. 2022 International journal of environmental research and public health
Help

The Flanks tab provides retrieving flanking sequences of a SNP on all molecules that have placements.

Genome context:
Select flank length:

Genomic regions, transcripts, and products
Top Help

NCBI Graphical Sequence Viewer display of the genomic region, transcripts and protein products for the reported RefSNP (rs).
Use the zoom option to view the nucleotides around the RefSNP and find other neighboring RefSNPs.
Visit Sequence Viewer for help with navigating inside the display and modifying the selection of displayed data tracks.

Software version is: 2.0.1.post820+afb47a3d